Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|May 23, 2007
Cyclin D1 down-regulation is essential for DBC2's tumor suppressor functionTakashi Yoshihara, Denise Collado, Masaaki HamaguchiBiochemical and Biophysical Research Communications|July 10, 2007
DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradationDenise Collado, Takashi Yoshihara, Masaaki HamaguchiJournal of Molecular Biology|October 7, 2006
DBC2 is essential for transporting vesicular stomatitis virus glycoproteinFaith K Chang, Noriko Sato, Noriko Kobayashi-Simorowski, et al.Journal of Molecular Biology|January 25, 2005
DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathwaysVeeraiah Siripurapu, Jennifer Meth, Noriko Kobayashi, et al.Methods in Molecular Biology (Clifton, N.J.)|March 25, 2015
Identification of the Rab5 binding site in p110β: assays for PI3Kβ binding to Rab5Rachel S Salamon, Hashem A Dbouk, Denise Collado, et al.Cancer Research|June 17, 2006
Haploinsufficiency of RAD51B causes centrosome fragmentation and aneuploidy in human cellsOsamu Date, Mari Katsura, Mari Ishida, et al.Nucleic Acids Research|February 4, 2006
Haploinsufficiency of the Mus81-Eme1 endonuclease activates the intra-S-phase and G2/M checkpoints and promotes rereplication in human cellsTakashi Hiyama, Mari Katsura, Takashi Yoshihara, et al.The EMBO Journal|January 30, 2004
XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cellsTakashi Yoshihara, Mari Ishida, Aiko Kinomura, et al.Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
DBC2, a candidate for a tumor suppressor gene involved in breast cancerMasaaki Hamaguchi, Jennifer L Meth, Christine von Klitzing, et al.Nucleic Acids Research|May 1, 2009
The ATR-Chk1 pathway plays a role in the generation of centrosome aberrations induced by Rad51C dysfunctionMari Katsura, Takanori Tsuruga, Osamu Date, et al.Pageof 1